Hinge Health, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Hinge Health, Inc. (HNGE) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $116.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-03
- Hinge Health, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $116.20M, a 591.67% increase from fiscal 2024.
- Hinge Health, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $16.80M, a 38.69% decline from fiscal 2023.
- Hinge Health, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $27.40M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $116.20M 10-K · filed 2026-03-03 |
| 2024-12-31 | $16.80M 10-K · filed 2026-03-03 |
| 2023-12-31 | $27.40M 10-K · filed 2026-03-03 |